Dublin, Jan. 18, 2024 (GLOBE NEWSWIRE) -- The "The World Market for Molecular Diagnostics, 12th Edition" report has been added to ResearchAndMarkets.com's offering.
The latest industry benchmark report, 'The World Market for Molecular Diagnostics, 12th Edition,' is now available, providing insightful analysis into the molecular diagnostics market trends and forecasts through 2028. The report, a comprehensive study, captures the evolution and expansion of the sector across various application segments and geographical regions.
Surging Demand in Molecular Diagnostics Applications
The publication offers a detailed investigation of the global market's dynamics, revealing a persistent demand in molecular diagnostics, especially within infectious diseases and cancer diagnostics spheres. Market segmentation is thoroughly assessed, including:
- Infectious Diseases
- Blood Screening
- Historical and Emerging Cancer Assays
- Transplant Diagnostics
- Inherited Diseases
A sharp increase in the acceptance of molecular diagnostics post-COVID-19 suggests a robust future for the industry, propelled by the need for rapid, precise, and actionable diagnostics in clinical settings.
Rising Importance of Molecular Diagnostics in Healthcare
Molecular diagnostics has revolutionized healthcare, offering rapid detection of infectious diseases, contributing to the accuracy of cancer diagnostics, and enabling personalized medicine through companion diagnostics. The report underscores its critical role in identifying AMR infections and understanding pharmacogenetics for effective treatment regimens.
Global and Regional Market Forecasts
The report forecasts growth within key market regions, highlighting North America and Europe as leading markets, while also examining the burgeoning potential in the Asia Pacific region. Valuable market insights for 2023-2028 include:
- Global Markets for Molecular Diagnostics by Applications
- Regional Analysis of North American, European, and Asia Pacific Markets
- Future Trends and Growth Opportunities
Competitive Landscape and Technological Advancements in Molecular Infectious Disease Diagnostics
Detailed within the report is the competitive scenario of molecular diagnostics. Pioneers in the field have brought to market an array of innovative technologies and tests, particularly for detecting infectious diseases, with sensitivity and specificity being key drivers of market adoption. The infectious disease sector, driven by the urgent need for accurate testing methods for HIV, Hepatitis, and other critical conditions, has seen significant growth. The report delves into subsegment analyses such as respiratory diseases and tuberculosis, offering an incisive global market forecast.
Enhancement of Blood Safety and Molecular Blood Screening Diagnostics
Initiatives aimed at improving blood transfusion safety have catalyzed the shift from conventional immunoassays to molecular diagnostics. The molecular blood screening diagnostics market is explored extensively, providing insights into how this transition is unfolding globally, with a keen focus on the impact in developing countries.
Integrative Technologies in Molecular Histology and Cancer Diagnostics
Molecular histology's market segment, including ISH tests, demonstrates its broad application in genetic disorder testing and cancer pathology. The report clarifies the upsurge in technologies such as FISH and CISH, particularly in RNA marker analysis for drug development.
Demand and Innovation in Molecular Transplant and Inherited Disease Diagnostics
A detailed review of the molecular transplant diagnostics sector highlights the amplified need for NGS and the deepening of competition among companies offering HLA gene characterization tests. Inherited disease diagnostics also receive comprehensive coverage, displaying advancements in SNP identification for disease risk assessment.
Strategic Insights for Stakeholders
The report delves into strategies that stakeholders need to adopt to bridge the gap between clinical research and practice, particularly in gene-based inherited disease diagnostics. This new edition stands as a vital resource for industry leaders, healthcare professionals, and market strategists, providing an essential compass for navigating the rapidly changing landscape of molecular diagnostics in the post-pandemic era.
Companies Mentioned
- Abbott Diagnostics
- Advanced Cell Diagnostics (Bio-Techne)
- Agena Bioscience
- Agendia BV
- Agilent Technologies (incl. Dako)
- Aidian Oy
- Altona Diagnostics
- Amoy Diagnostics
- Applied Spectral Imaging
- ARUP Laboratories
- Asuragen Inc. (Bio-Techne)
- Becton, Dickinson & Co. (BD)
- Beijing Genomics Institute (BGI)
- Berry Genomics
- binx health
- Bio-Rad Laboratories, Inc.
- Biocartis
- Biodesix
- bioMérieux
- Bioneer
- CareDx, Inc.
- Danaher
- DiaSorin
- Eiken Chemical
- Exact Sciences Corp.
- GenMark Diagnostics (Roche)
- Genotypic Technology Pvt. Ltd.
- Greiner Bio-One GmbH
- Grifols, S. A
- Hologic, Inc.
- Illumina, Inc.
- Meridian Bioscience Inc
- Myriad Genetics, Inc.
- NanoString Technologies, Inc.
- NeuroMoDX
- Oxford Nanopore Technologies Ltd
- Promega Corporation
- Qiagen
- QuantuMDx Group
- QuidelOrtho
- Revvity
- Rheonix, Inc.
- Roche Diagnostics
- Seegene
- Sekisui Diagnostics LLC
- Sherlock Biosciences
- Standard BioTools
- T2 Biosystems
- Thermo Fisher Scientific Inc.
- Vela Diagnostics
- Veracyte, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/lg0uce
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
